• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MEM
Click for more information
0.00% 0.5¢

MEMPHASYS LIMITED. - Announcements

Market Cap $13.00M  ! watchlist Created with Sketch. Add to my watchlist

Memphasys Limited is an Australia-based reproductive biotechnology company. The Company... Memphasys Limited is an Australia-based reproductive biotechnology company. The Company is engaged in developing medical devices, diagnostics, and media with application to assisted reproductive technology (ART) in humans and animals. The Company's product pipeline includes Felix, RoXsta, and AI-Port. Its advanced product, the Felix System, is a patented automated device for quickly and gently separating sperm from a semen sample for use in ART procedures. The Felix device consists of two main components: a console, which supplies electrical power, and a sterile disposable cartridge for sperm isolation and selection. RoXsta is an in-vitro diagnostic device that assesses semen and other bodily fluids for oxidative stress load. RoXsta also has an application as part of a suite of products that can support the animal industry. AI-Port has been developed for the purpose of maintaining the viability of livestock semen for up to seven days at a temperature range of 22 - 25 degrees Celsius.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
MEMNuSep strengthens leadership team with appointment of CFO07/03/11
MEMCorrection to the NTA calculation04/03/11
MEMASX Waiver for the General Meeting03/03/11
MEMResults of Meeting and Shareholder Presentaion01/03/11
MEMNuSep Half Year Results Dec 2010PRICE SENSITIVE25/02/11
MEMReplacement Prospectus for the Dec 2010 SPP Bonus Share Opti14/02/11
MEMProspectus for the Dec 2010 SPP Bonus Share OptionsPRICE SENSITIVE04/02/11
MEMNotice of General Meeting28/01/11
MEMChange of Director's Interest Notice25/01/11
MEMAppendix 3B24/01/11
MEMNuSep SPP Oversubscribed Raising $1m18/01/11
MEMChange of Director's Interest Notice07/01/11
MEMNuSep Share Trading Policy29/12/10
MEMNuSep Investor Presentations20/12/10
MEMNuSep Shareholders Newsletter20/12/10
MEMNuSep SPP Pricing15/12/10
MEMNuSep Share Purchase Plan and Investor Presentations13/12/10
MEMNuSep SPP Investor Presentation Dates10/12/10
MEMShare Purchase Plan Cleansing Notice10/12/10
MEMNuSep Announces Share Purchase PlanPRICE SENSITIVE09/12/10
MEMChange of Director's Interest Notice06/12/10
MEMChange of Director's Interest Notice30/11/10
MEMNSP enters $1b Asian blood plasma market- Audio Broadcast30/11/10
MEMNSP AGM PresentationPRICE SENSITIVE29/11/10
MEMNuSep completes $1.9m Share PlacementPRICE SENSITIVE29/11/10
MEMResults of AGM26/11/10
MEMTrading HaltPRICE SENSITIVE25/11/10
MEMNuSep enters $1 billion Asian blood plasma marketPRICE SENSITIVE24/11/10
MEMNuSep is Awarded Government GrantPRICE SENSITIVE04/11/10
MEMNuSep Sues Expedeon for Patent InfringementPRICE SENSITIVE04/11/10
MEMNuSep Annual Report 201029/10/10
MEMNuSep Notice of Meeting 2010 AGM22/10/10
MEMNuSep pays Final Debt Instalment and is now Debt FreePRICE SENSITIVE18/10/10
MEMNuSep Lodges 2 Gel Patents14/10/10
MEMNuSep Completes Small Shareholder Buyback11/10/10
MEMAudit Accounts for Year ended 30 June 201030/09/10
MEMSpermSep Collaboration with Uni of Newcastle27/09/10
MEMNSP Small Holding Share Buy Back20/09/10
MEMEstablishment of a Scientific Committee09/09/10
MEMNuSep Maiden $3.29m Net Profit - Broadcast25/08/10
MEMNuSep Investor Presentation18/08/10
MEMNuSep announces Maiden $3.29m Net ProfitPRICE SENSITIVE17/08/10
MEMNuSep Small Holding Share Buy Back11/08/10
MEMNuSep Investor Presentations05/08/10
MEMNuSep Announces Buyback of Small Shareholders30/07/10
MEMChange of Director's Interest Notice26/07/10
MEMChange of Director's Interest Notice14/07/10
MEMChange of Director's Interest Notice08/07/10
MEMAppendix 3B30/06/10
MEMChange of Director's Interest Notice15/06/10
MEMChange in substantial holding08/06/10
MEMChange of Director's Interest Notice07/06/10
MEMShareholder Notices01/06/10
MEMTop 20 securityholders01/06/10
MEMChange of Director's Interest Notice31/05/10
MEMChange of Director's Interest Notice28/05/10
MEMNuSep's Rights Issue Raises $4.5M26/05/10
MEMChange of Director's Interest Notices25/05/10
MEMChange of Director's Interest Notice x 224/05/10
MEMChange in substantial holding24/05/10
MEMChange of Director's Interest Notice21/05/10
MEMChange of Director's Interest Notice21/05/10
MEMNuSep Investor Presentation21/05/10
MEMChange of Director's Interest Notice19/05/10
MEMNuSep Shareholder Newsletter17/05/10
MEMChange of Director's Interest Notice17/05/10
MEMNSP Change of Interests of substantial holding amended17/05/10
MEMChange of Director's Interest Notice14/05/10
MEMChange in substantial holding13/05/10
MEMChange of Director's Interest Notice11/05/10
MEM1- 2 Rights Issue Timetable and Investor Presentation Dates07/05/10
MEMReplacement Rights Issue ProspectusPRICE SENSITIVE06/05/10
MEMBecoming a substantial holder04/05/10
MEMChange in substantial holding03/05/10
MEMChange in substantial holding03/05/10
MEMDirector Share Purchase30/04/10
MEMAppendix 3B30/04/10
MEMChange of Director's Interest Notice x 427/04/10
MEMChange of Director's Interest Notice23/04/10
MEMInvestor Presentation20/04/10
MEMInvestor Presentation20/04/10
MEMNon-Renounceable Issue ProspectusPRICE SENSITIVE16/04/10
MEMDirector Loan Conversion16/04/10
MEMResults of Meeting14/04/10
MEMInvestor Presentations and Timetable for Rights IssuePRICE SENSITIVE26/03/10
MEMSpermSep Patent Application LodgedPRICE SENSITIVE23/03/10
MEMSubstantial Shareholder Notice19/03/10
MEMNuSep to Fund BioInquire Acquisition and IVF SpermSep Prese19/03/10
MEMNuSep to Fund BioInquire Acquisition and IVF SpermSepPRICE SENSITIVE17/03/10
MEMNSP SpermSep European Patent Presentation09/03/10
MEMSpermSep European Patent GrantedPRICE SENSITIVE08/03/10
MEMNuSep Completes Acquisition and Upgrades Profit Forecast18/02/10
MEMNuSep Completes Acquisition and Upgrades Profit ForecastPRICE SENSITIVE18/02/10
MEMNuSep Half Year Profit Presentation17/02/10
MEMNuSep Announces Maiden Operational ProfitPRICE SENSITIVE16/02/10
MEMChange in substantial holding15/02/10
MEMAppendix 3B15/02/10
MEMChange in substantial holding08/02/10
MEMAppendix 3B08/01/10
MEMChange in substantial holding22/12/09
MEMNuSep strengthens leadership team with appointment of CFO
07/03/11
MEMCorrection to the NTA calculation
04/03/11
MEMASX Waiver for the General Meeting
03/03/11
MEMResults of Meeting and Shareholder Presentaion
01/03/11
MEMNuSep Half Year Results Dec 2010
25/02/11PRICE SENSITIVE
MEMReplacement Prospectus for the Dec 2010 SPP Bonus Share Opti
14/02/11
MEMProspectus for the Dec 2010 SPP Bonus Share Options
04/02/11PRICE SENSITIVE
MEMNotice of General Meeting
28/01/11
MEMChange of Director's Interest Notice
25/01/11
MEMAppendix 3B
24/01/11
MEMNuSep SPP Oversubscribed Raising $1m
18/01/11
MEMChange of Director's Interest Notice
07/01/11
MEMNuSep Share Trading Policy
29/12/10
MEMNuSep Investor Presentations
20/12/10
MEMNuSep Shareholders Newsletter
20/12/10
MEMNuSep SPP Pricing
15/12/10
MEMNuSep Share Purchase Plan and Investor Presentations
13/12/10
MEMNuSep SPP Investor Presentation Dates
10/12/10
MEMShare Purchase Plan Cleansing Notice
10/12/10
MEMNuSep Announces Share Purchase Plan
09/12/10PRICE SENSITIVE
MEMChange of Director's Interest Notice
06/12/10
MEMChange of Director's Interest Notice
30/11/10
MEMNSP enters $1b Asian blood plasma market- Audio Broadcast
30/11/10
MEMNSP AGM Presentation
29/11/10PRICE SENSITIVE
MEMNuSep completes $1.9m Share Placement
29/11/10PRICE SENSITIVE
MEMResults of AGM
26/11/10
MEMTrading Halt
25/11/10PRICE SENSITIVE
MEMNuSep enters $1 billion Asian blood plasma market
24/11/10PRICE SENSITIVE
MEMNuSep is Awarded Government Grant
04/11/10PRICE SENSITIVE
MEMNuSep Sues Expedeon for Patent Infringement
04/11/10PRICE SENSITIVE
MEMNuSep Annual Report 2010
29/10/10
MEMNuSep Notice of Meeting 2010 AGM
22/10/10
MEMNuSep pays Final Debt Instalment and is now Debt Free
18/10/10PRICE SENSITIVE
MEMNuSep Lodges 2 Gel Patents
14/10/10
MEMNuSep Completes Small Shareholder Buyback
11/10/10
MEMAudit Accounts for Year ended 30 June 2010
30/09/10
MEMSpermSep Collaboration with Uni of Newcastle
27/09/10
MEMNSP Small Holding Share Buy Back
20/09/10
MEMEstablishment of a Scientific Committee
09/09/10
MEMNuSep Maiden $3.29m Net Profit - Broadcast
25/08/10
MEMNuSep Investor Presentation
18/08/10
MEMNuSep announces Maiden $3.29m Net Profit
17/08/10PRICE SENSITIVE
MEMNuSep Small Holding Share Buy Back
11/08/10
MEMNuSep Investor Presentations
05/08/10
MEMNuSep Announces Buyback of Small Shareholders
30/07/10
MEMChange of Director's Interest Notice
26/07/10
MEMChange of Director's Interest Notice
14/07/10
MEMChange of Director's Interest Notice
08/07/10
MEMAppendix 3B
30/06/10
MEMChange of Director's Interest Notice
15/06/10
MEMChange in substantial holding
08/06/10
MEMChange of Director's Interest Notice
07/06/10
MEMShareholder Notices
01/06/10
MEMTop 20 securityholders
01/06/10
MEMChange of Director's Interest Notice
31/05/10
MEMChange of Director's Interest Notice
28/05/10
MEMNuSep's Rights Issue Raises $4.5M
26/05/10
MEMChange of Director's Interest Notices
25/05/10
MEMChange of Director's Interest Notice x 2
24/05/10
MEMChange in substantial holding
24/05/10
MEMChange of Director's Interest Notice
21/05/10
MEMChange of Director's Interest Notice
21/05/10
MEMNuSep Investor Presentation
21/05/10
MEMChange of Director's Interest Notice
19/05/10
MEMNuSep Shareholder Newsletter
17/05/10
MEMChange of Director's Interest Notice
17/05/10
MEMNSP Change of Interests of substantial holding amended
17/05/10
MEMChange of Director's Interest Notice
14/05/10
MEMChange in substantial holding
13/05/10
MEMChange of Director's Interest Notice
11/05/10
MEM1- 2 Rights Issue Timetable and Investor Presentation Dates
07/05/10
MEMReplacement Rights Issue Prospectus
06/05/10PRICE SENSITIVE
MEMBecoming a substantial holder
04/05/10
MEMChange in substantial holding
03/05/10
MEMChange in substantial holding
03/05/10
MEMDirector Share Purchase
30/04/10
MEMAppendix 3B
30/04/10
MEMChange of Director's Interest Notice x 4
27/04/10
MEMChange of Director's Interest Notice
23/04/10
MEMInvestor Presentation
20/04/10
MEMInvestor Presentation
20/04/10
MEMNon-Renounceable Issue Prospectus
16/04/10PRICE SENSITIVE
MEMDirector Loan Conversion
16/04/10
MEMResults of Meeting
14/04/10
MEMInvestor Presentations and Timetable for Rights Issue
26/03/10PRICE SENSITIVE
MEMSpermSep Patent Application Lodged
23/03/10PRICE SENSITIVE
MEMSubstantial Shareholder Notice
19/03/10
MEMNuSep to Fund BioInquire Acquisition and IVF SpermSep Prese
19/03/10
MEMNuSep to Fund BioInquire Acquisition and IVF SpermSep
17/03/10PRICE SENSITIVE
MEMNSP SpermSep European Patent Presentation
09/03/10
MEMSpermSep European Patent Granted
08/03/10PRICE SENSITIVE
MEMNuSep Completes Acquisition and Upgrades Profit Forecast
18/02/10
MEMNuSep Completes Acquisition and Upgrades Profit Forecast
18/02/10PRICE SENSITIVE
MEMNuSep Half Year Profit Presentation
17/02/10
MEMNuSep Announces Maiden Operational Profit
16/02/10PRICE SENSITIVE
MEMChange in substantial holding
15/02/10
MEMAppendix 3B
15/02/10
MEMChange in substantial holding
08/02/10
MEMAppendix 3B
08/01/10
MEMChange in substantial holding
22/12/09
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
0.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $13.00M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $935 187K

Buyers (Bids)

No. Vol. Price($)
6 5639600 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 11066843 9
View Market Depth
Last trade - 11.48am 28/11/2024 (20 minute delay) ?
MEM (ASX) Chart

Top Stories

Chaos reigns markets – so let's take stock of where we're at ahead of December

For many people, it feels like the world has been getting crazier each year since 2020 (or 2016.) It's likely to continue
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.